DOW JONES21,087.27-829.89 -3.79%
S&P 5002,478.12-106.47 -4.12%
NASDAQ7,391.30-308.80 -4.01%

B. Riley FBR Maintains Buy on Harrow Health, Lowers Price Target to $12

B. Riley FBR analyst Andrew D'Silva maintains Harrow Health (NASDAQ:HROW) with a Buy and lowers the price target from $12.75 to $12.

Benzinga · 03/16/2020 11:15

B. Riley FBR analyst Andrew D'Silva maintains Harrow Health (NASDAQ:HROW) with a Buy and lowers the price target from $12.75 to $12.